Literature DB >> 26601801

Clinical and mutation profile of multicentric osteolysis nodulosis and arthropathy.

Gandham SriLakshmi Bhavani1, Hitesh Shah2, Anju Shukla1, Neerja Gupta3, Kalpana Gowrishankar4, Anand P Rao5, Madhulika Kabra3, Meenal Agarwal6, Prajnya Ranganath7,8, Alka V Ekbote9, Shubha R Phadke6, Asha Kamath10, Ashwin Dalal8, Katta Mohan Girisha1.   

Abstract

Multicentric osteolysis nodulosis and arthropathy (MONA) is an infrequently described autosomal recessive skeletal dysplasia characterized by progressive osteolysis and arthropathy. Inactivating mutations in MMP2, encoding matrix metalloproteinase-2, are known to cause this disorder. Fifteen families with mutations in MMP2 have been reported in literature. In this study we screened thirteen individuals from eleven families for MMP2 mutations and identified eight mutations (five novel and three known variants). We characterize the clinical, radiographic and molecular findings in all individuals with molecularly proven MONA from the present cohort and previous reports, and provide a comprehensive review of the MMP2 related disorders.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  MMP2; Torg-Winchester syndrome; multicentric osteolysis nodulosis and arthropathy

Mesh:

Substances:

Year:  2015        PMID: 26601801     DOI: 10.1002/ajmg.a.37447

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

Review 1.  A review of skeletal dysplasia research in India.

Authors:  A Uttarilli; H Shah; A Shukla; K M Girisha
Journal:  J Postgrad Med       Date:  2018 Apr-Jun       Impact factor: 1.476

2.  Identification of fibrinogen as a natural inhibitor of MMP-2.

Authors:  Hassan Sarker; Eugenio Hardy; Ayman Haimour; Walter P Maksymowych; Lorenzo D Botto; Carlos Fernandez-Patron
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

3.  A novel mutation in the matrix metallopeptidase 2 coding gene associated with intrafamilial variability of multicentric osteolysis, nodulosis, and arthropathy.

Authors:  Liisa Kröger; Tuija Löppönen; Leena Ala-Kokko; Heikki Kröger; Hanna-Mari Jauhonen; Kaisa Lehti; Jarmo Jääskeläinen
Journal:  Mol Genet Genomic Med       Date:  2019-07-03       Impact factor: 2.183

4.  Different roles of matrix metalloproteinase 2 in osteolysis of skeletal dysplasia and bone metastasis (Review).

Authors:  Xiumao Li; Libin Jin; Yanbin Tan
Journal:  Mol Med Rep       Date:  2020-11-25       Impact factor: 2.952

Review 5.  Lost bones: differential diagnosis of acro-osteolysis seen by the pediatric rheumatologist.

Authors:  Elizaveta Limenis; Jennifer Stimec; Peter Kannu; Ronald M Laxer
Journal:  Pediatr Rheumatol Online J       Date:  2021-07-14       Impact factor: 3.054

6.  Bisphosphonates in multicentric osteolysis, nodulosis and arthropathy (MONA) spectrum disorder - an alternative therapeutic approach.

Authors:  Karin Pichler; Daniela Karall; Dieter Kotzot; Elisabeth Steichen-Gersdorf; Alexandra Rümmele-Waibel; Laureane Mittaz-Crettol; Julia Wanschitz; Luisa Bonafé; Kathrin Maurer; Andrea Superti-Furga; Sabine Scholl-Bürgi
Journal:  Sci Rep       Date:  2016-09-30       Impact factor: 4.379

7.  Multicentric Osteolysis, Nodulosis, and Arthropathy in two unrelated children with matrix metalloproteinase 2 variants: Genetic-skeletal correlations.

Authors:  Hanan Elsebaie; Mohamed Abdelhafiz Mansour; Solaf M Elsayed; Shady Mahmoud; Tamer A El-Sobky
Journal:  Bone Rep       Date:  2021-07-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.